Table 4.
The baseline levels of clinical laboratory-based tests of the participants in the Jinchang Cohort Study (mean ± standard deviation)
| Variables | Male | Female | Total |
|---|---|---|---|
| Haematological traits | |||
| WBC (10 9/l) | 6.6 (1.7) | 5.7 (1.5) | 6.2 (1.7) |
| RBC (10 12/l) | 5.2 (0.4) | 4.6 (0.4) | 5 (0.5) |
| PLT (10 9/l) | 166.6 (47.5) | 188.6 (51.7) | 175.1 (50.3) |
| Haemoglobin (g/l) | 158.6 (10.5) | 136.5 (12.2) | 150.1 (15.5) |
| FBG (mmol/l) | 5.5 (1.5) | 5.2 (1.2) | 5.4 (1.4) |
| Hepatic function | |||
| ALT (U/l) | 39.7 (32.7) | 25.8 (21.4) | 34.4 (29.6) |
| AST (U/l) | 37.0 (22) | 31.9 (16) | 35.0 (20.1) |
| ALP (U/l) | 71.8 (20.7) | 63 (22.9) | 68.5 (21.9) |
| GGT (U/l) | 45.4 (63) | 24.5 (34.4) | 37.5 (55) |
| Total bilirubin (μmol/l) | 17.2 (7.1) | 15 (5.5) | 16.3 (6.6) |
| Direct bilirubin (μmol/l) | 4.9 (2.9) | 3.4 (1.9) | 4.3 (2.6) |
| Indirect bilirubin (μmol/l) | 12.3 (5) | 11.6 (4.2) | 12 (4.7) |
| Renal function | |||
| BUN (mmol/l) | 5.7 (1.5) | 5 (1.4) | 5.4 (1.5) |
| Serum Creatinine (μmol/l) | 77.3 (17.6) | 60 (12.6) | 70.7 (18) |
| Uric Acid (μmol/l) | 361.5 (74.7) | 270.8 (59.3) | 327.3 (82.1) |
| Lipids | |||
| TC (mmol/l) | 4.7 (0.9) | 4.8 (0.9) | 4.7 (0.9) |
| TG (mmol/l) | 2.2 (1.7) | 1.6 (1.1) | 1.9 (1.5) |
| HDL-C (mmol/l) | 1.3 (0.3) | 1.5 (0.4) | 1.4 (0.4) |
| LHL-C (mmol/l) | 3 (0.7) | 3.1 (0.8) | 3.1 (0.8) |